Abernathy James Paul
- SEC CIK
- 0001261687
No open-market purchases or sales filed in the past year.
Current role at each company
- NHC National Healthcare CorpDirectoras of May 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Abernathy James Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing) | Aug 14 | 1 day | Abernathy James PaulDirector | SSaleShares of Common Stock | −1.60K | $127.00 | −$203.8K | −4.6%33.3K after | |
| Aug 28, 2023 (view filing) | Aug 24 | 4 days | Abernathy James PaulDirector | SSaleShares of Common Stock | −1.55K | $68.22 | −$105.7K | −4.9%29.8K after | |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Abernathy James PaulDirector | PPurchaseShares of Common Stock | +2.18K | $57.45 | +$125.0K | +7.4%31.4K after |